Lacosamide

Strengths & Sizes

Note: product and packaging images are not actual size

NDC#31722-812-60
UPC Code331722812603
ImprintJ/ 12

Download Label

Download HDA Sheet

Note: product and packaging images are not actual size

NDC#31722-813-60
UPC Code331722813600
ImprintJ/13

Download Label

Download HDA Sheet

Note: product and packaging images are not actual size

NDC#31722-814-60
UPC Code331722814607
ImprintJ/14

Download Label

Download HDA Sheet

Note: product and packaging images are not actual size

NDC#31722-815-60
UPC Code331722815604
ImprintJ/15

Download Label

Download HDA Sheet

Indications

Lacosamide tablets are indicated for: · Treatment of partial-onset seizures in patients 1 month of age and older (1.1) · Adjunctive therapy in the treatment of primary generalized tonic-clonic seizures in patients 4 years of age and older (1.2)

Product Info

Dosage FormTablet

TE CodeAB

Brand ReferenceVimpat

Therapeutic CategoryAnticonvulsants

Pronunciationla KOE sa mide

Inactive Ingredientscolloidal silicon dioxide, crospovidone, hydroxypropyl cellulose, hypromellose, lecithin, low substituted hydroxypropyl cellulose, magnesium stearate, microcrystalline cellulose, polyethylene glycol, polyvinyl alcohol, talc and titanium dioxide. In addition to this the 50 mg tablets contain FD&C Blue #2/indigo carmine aluminum lake, iron oxide black and iron oxide red. 100 mg tablets contain iron oxide yellow. 150 mg tablets contain iron oxide black, iron oxide red and iron oxide yellow. 200 mg tablets contain FD&C Blue #2/indigo carmine aluminum lake.